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According to the second edition of the International 
Classification of Headache Disorders (ICHD-II)1, migrain-
ous infarction (MI) is a complication of migraine with 
aura. MI is diagnosed when one or more aura symptoms 
last longer than 60 minutes, and neuroradiological stud-
ies demonstrate ischemic stroke that potentially explains 
the symptoms. Stroke should not be attributed to anoth-
er disorder. The ICHD-II also defines sporadic hemiplegic 
migraine (SHM) as a subtype of migraine with aura asso-
ciated with fully reversible motor weakness in association 
to the typical aura symptoms (visual, sensory or dyspha-
sic aura). Unlike familial hemiplegic migraine (FHM), fa-
milial history of migraine with motor weakness in first- or 
second-degree relatives is absent. MI in childhood is very 
rare and epidemiological studies are scarce2. Reports of 
incidence of migrainous stroke in this group range from 
0.5%2 to 1.7%3. A fairly and diligent review of the literature 
found no previous reports of MI during childhood follow-
ing SHM in Brazil.
Herein we report a case of MI following SHM in a child. 
We obtained written informed consent to publish the 
case, as well as the results of genetic testing. The princi-
ples outlined in the declaration of Helsinki were followed.
CASE
A 10-year-old boy was initially referred to our service on 
May of 2004, with a 2-year history of attacks of bifrontal and 
throbbing headache, preceded by right hemi-hypoesthesia and 
hemiparesis that typically lasted less than 60 minutes. Head-
ache attacks were of moderate intensity and were associated 
with photophobia and phonophobia. Frequency was around 3 
per month and duration ranged from 10 to 72 hours.
Family reported a single episode of headache in which the 
associated right hemiparesis lasted about three days. Although 
attack was longer and clearly not suggestive of a benign migraine 
attack, it had not been investigated.
The patient had no relevant prior medical history. Relevant 
familial history included mother suffering from migraine with vi-
sual aura, and brother with a past episode of transient left hemi-
paresis (without headache) in the context of varicella infection.
Two months before the first consultation, patient suffered 
a partial seizure, characterized by right hemi-body hypertonia, 
cephalic deviation and gaze shift to the right side, during a typ-
ical attack of hemiplegic migraine. Patient recovered totally and 
neurological exam was normal. Magnetic resonance imaging re-
vealed a left thalamic (pulvinar) lesion, suggestive of ischemia 
(Fig 1). The patient was then referred to our division for investi-
gation and treatment.
A comprehensive complementary investigation with blood 
tests, imaging tests, genetic tests, EEG and CSF for ischemic 
stroke was performed and revealed no abnormalities. Treat-
ment with flunarizine yielded adequate control of the migraine 
attacks, but it was suspended due to significant drowsiness and 
weight gain. Patient responded well to propranolol and is free 
of headaches since then (headache free for 2 years).
Mutation screening
Screening for DNA mutations were conducted on peripher-
al blood. We performed sequencing of the coding regions and 
exon-intron boundaries of the genes previously associated with 
FHM (CACNA1A, ATP1A2, SCN1A)4, including the promoter re-
gions for the first two. Analyses showed only one alteration in 
Fig 1. Coronal T2 weighted [A] and axial T2-weighted FLAIR [B] mag-
netic resonance imaging showing left thalamus (pulvinar) infarction.
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exon 8 of ATP1A2, a heterozygous deletion of 3 nucleotides (TTC) 
predicting F304del in the encoded protein (Fig 2A). The protein 
location of this abnormality is not conserved across different 
species. RFLP (restriction fragment length polymorphism) anal-
ysis showed that this abnormality was present neither in other 
family members (parents and brother) nor in 200 control chro-
mosomes (Fig 2B). We also excluded the most common muta-
tions associated with mitochondrial encephalomyopathy, lactic 
acidosis, and stroke-like episodes or MELAS (A3243G in mito-
chondrial DNA) and cerebral autosomal dominant arteriopathy 
with subcortical infarcts and leukoencephalopathy or CADASIL 
(exons 3 and 4 of NOTCH3).
DISCUSSION
The association of MI and SHM in childhood is poor-
ly understood due to the rarity of both entities. Among 
cases of ischemic stroke in childhood, MI accounted for 
17.4%5 of the cases in a single retrospective study con-
ducted without a standardized protocol, hence suscepti-
ble to biases. MI has not been described in several adult 
cases of FHM6 and SHM7 with neurological deficits last-
ing for several days.
According to some authors, the ICHD-II criteria for MI 
are too restrictive for use in the pediatric population3,8, re-
quiring a revision. It is well known that the clinical features 
of migraine vary as a function of age, and that children are 
more likely to have attacks of shorter duration and bilat-
eral location. These and other differences between the 
pediatric and adult populations were not fully addressed 
by the ICHD-II criteria. Failure to fulfill the migraine with 
aura criteria is one of the possible reasons to explain the 
small number of MI cases previously reported.
Ischemic stroke during childhood is an infrequent con-
dition5 with many potential risk factors. Accordingly, the 
diagnostic process should be directed towards identify-
ing as many of risk factors as possible. The proportion of 
patients where no risk factors are identified has progres-
sively decreased as a function of our better understand-
ing of the etiology of MI, which has been accompanied 
by improved investigation methods9. The extensive inves-
tigation necessary to exclude other causes of ischemic 
stroke is probably another reason for the lack of MI diag-
nosis in childhood.
Our patient fulfilled ICHD-II criteria for MI and for 
SHM. The complementary studies performed to exclude 
other causes of ischemic stroke were those suggested by 
the Royal College of Physicians9. After screening the three 
genes previously associated to FHM, we could only find a 
3 nucleotide deletion in the ATP1A2 gene. This modifica-
tion was not described before and predicts one aminoacid 
deletion (F304del) that does not lead to a truncated pro-
tein. Although it was not detected in controls, this region 
is not conserved among different species, which could 
suggest that it represents a polymorphism. There are few 
Fig 2. Sequencing analysis [A] and RFLP study 
with MboII [B]. In [A], the sequence became 
unreadable after a heterozygous modification 
(*) caused by two superimposed sequences: the 
normal one (top) and the one with TTC deletion 
(bottom). In [B], the mutation leads to the loss 
of one MboII restriction site (left) and an abnor-
mal band (306bp) could be detected after aga-
rose gel electrophoresis (right). M: molecular 
weight marker; U: uncut; +: patient; C: control.
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reports of mutations in FHM genes in SHM patients4,10. 
Phenotype-genotype correlations in these patients and 
family members demonstrated the presence of mutation 
carriers in migraine with aura (or in individuals without 
migraine)4,10. Thus, the mutation is not sufficient to indi-
cate pathogenicity. Further studies are needed to estab-
lish the role of this mutation in this phenotype.
Migraine complications should be promptly investi-
gated to exclude other causes. Prophylaxis should be ini-
tiated as soon as possible to control migraine attacks that 
could lead to additional complications.
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